July 28, 2016—Senate Judiciary Chairman Charles Grassley (R-Iowa) wants the Centers for Medicare & Medicaid Services to investigate “an alarming trend in spending growth” in the catastrophic coverage portion of Medicare’s prescription drug benefit, including whether drug companies might be exploiting the benefit.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)